Private
Research Grant for Rett Syndrome
Published by International Rett Syndrome Foundation
GrantRett SyndromeIRSF believes that research into a variety of Rett and Rett-related topics is necessary to create treatments and eventual cures for every individual living with Rett syndrome. We proudly invest in such research at every stage: from basic science that can change the way we think about MeCP2 to clinical research that directly impacts potential treatments. We also help connect Rett researchers with external funding opportunities.
View this resource Bookmark this resourceVIB focuses on translating basic scientific results into pharmaceutical, agricultural and industrial applications.
View this resource Bookmark this resourceGenextra is one of Italy’s largest and most experienced life sciences investment firms.
View this resource Bookmark this resourceIn addition to traditional grantmaking to support people and organizations working toward our missions in Science, Education, and within our communities, the Chan Zuckerberg Initiative makes venture investments in impact-focused companies, builds tools and products that we can scale and give away for free, and supports capacity building to achieve progress across our work.
View this resource Bookmark this resource
Postdoctoral Research Fellowship Award
Published by Cystic Fibrosis Foundation
Cystic FibrosisFellowshipPostdoctoral research fellowship awards are offered to MDs, PhDs, and MD/PhDs who are interested in conducting basic research related to cystic fibrosis.
View this resource Bookmark this resourceThe Progeria Research Foundation (PRF) is a driving force worldwide in finding treatments and the cure for Progeria and its aging-related disorders, including heart disease. We invite qualified scientists with faculty appointments or the equivalent to submit applications for the upcoming grant cycle.
View this resource Bookmark this resource
Research Grants for Angelman Syndrome
Published by Angelman Syndrome Foundation
Angelman SyndromeGrantThe ASF Scientific Advisory Committee identified the following areas of unmet need in AS research. Priority will be given to the following topics:
Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion.
Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS.
Projects studying delivery of therapies and potential for improvement.
Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.
Proposals that do not address these topics are still welcome and will be given full consideration.
European Society for Immunodeficiencies (ESID) Bridge Grant
Published by European Society for Immunodeficiencies
GrantPrimary ImmunodeficiencyESID wants to invest in the future of researchers and clinicians committed to PIDs. Therefore ESID Bridge Grants aim to allow trainees working on PIDs to continue their activity in the field of PID in their institution or another institution during short periods of time until they can find other financial sources, thus avoiding the interruption of their training process.
View this resource Bookmark this resource